1. Home
  2. VRTX vs LMT Comparison

VRTX vs LMT Comparison

Compare VRTX & LMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vertex Pharmaceuticals Incorporated

VRTX

Vertex Pharmaceuticals Incorporated

N/A

Current Price

$517.10

Market Cap

135.6B

Sector

Technology

ML Signal

N/A

Logo Lockheed Martin Corporation

LMT

Lockheed Martin Corporation

N/A

Current Price

$566.12

Market Cap

127.4B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
VRTX
LMT
Founded
1989
1912
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Military/Government/Technical
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
135.6B
127.4B
IPO Year
2007
1995

Fundamental Metrics

Financial Performance
Metric
VRTX
LMT
Price
$517.10
$566.12
Analyst Decision
Buy
Buy
Analyst Count
32
24
Target Price
$595.36
★ $660.86
AVG Volume (30 Days)
1.3M
★ 1.4M
Earning Date
11-02-2026
10-22-2026
Dividend Yield
N/A
★ 2.52%
EPS Growth
★ 836.54
N/A
EPS
10.90
★ 22.36
Revenue
$2,488,652,000.00
★ $75,048,000,000.00
Revenue This Year
$10.46
$8.48
Revenue Next Year
$10.53
$7.03
P/E Ratio
$47.77
★ $25.59
Revenue Growth
★ 46.20
5.64
52 Week Low
$412.27
$437.25
52 Week High
$568.67
$692.00

Technical Indicators

Market Signals
Indicator
VRTX
LMT
Relative Strength Index (RSI) 41.75 43.84
Support Level $493.75 $561.85
Resistance Level $536.58 $608.67
Average True Range (ATR) 15.90 17.23
MACD -3.73 -6.93
Stochastic Oscillator 4.74 4.86

Price Performance

Historical Comparison
VRTX
LMT

About VRTX Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex is focused on diversifying its portfolio through Casgevy (gene-editing therapy for beta thalassemia and sickle-cell disease), Journavx (non-opioid pain drug for moderate-to-severe acute pain), and Palsonify (for acromegaly). Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases, cell therapies to deliver a functional cure for type 1 diabetes, povetacicept (for IgA nephropathy).

About LMT Lockheed Martin Corporation

Lockheed Martin is the world's largest defense contractor and has dominated the Western market for high-end fighter aircraft since it won the F-35 Joint Strike Fighter program in 2001. Aeronautics is Lockheed's largest segment, which derives upward of two-thirds of its revenue from the F-35. Lockheed's remaining segments are rotary and mission systems, encompassing the Sikorsky helicopter business; missiles and fire control, which creates missiles and missile defense systems; and space systems, which produces satellites and receives equity income from the United Launch Alliance joint venture.

Share on Social Networks: